Nichol Ochsner | Vice President of Investor Relations |
Richard Pascoe | CEO |
LaDuane Clifton | Chief Financial Officer |
Travis Mickle | President and Co-Founder |
Christal Mickle | Chief Product Development Officer and Co-Founder |
Joshua Schafer | Chief Commercial Officer and Executive Vice President, Business Development |
Jonathan Aschoff | ROTH MKM Partners |
Louise Chen | Cantor Fitzgerald |
Oren Livnat | H.C. Wainwright |
Good day, and welcome to the Zevra Therapeutics Fourth Quarter and Full Year 2022 Update Call. [Operator Instructions] Please be advised that today's call is being recorded.
I want to hand the call over to Zevra's Vice President of Investor Relations and Corporate Communications, Nichol Ochsner. Thank you.
You may begin.